In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epitheli... - 0 views
-
we functionally validated a potent EOC oncogene, KPNB1, and showed its clinical relevance to human EOC
-
a well-established antiparasitic drug, ivermectin, has antitumor effects on EOC through its inhibition of KPNB1
-
EOC has high intertumor and intratumor heterogeneity at the molecular and epigenetic levels
- ...22 more annotations...